These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 29243465
1. Atypical hemolytic-uremic syndrome. Kaartinen K, Martola L, Meri S. Duodecim; 2017; 133(6):539-47. PubMed ID: 29243465 [Abstract] [Full Text] [Related]
2. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome. Cugno M, Gualtierotti R, Possenti I, Testa S, Tel F, Griffini S, Grovetti E, Tedeschi S, Salardi S, Cresseri D, Messa P, Ardissino G. J Thromb Haemost; 2014 Sep; 12(9):1440-8. PubMed ID: 24853860 [Abstract] [Full Text] [Related]
3. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report. Kourouklaris A, Ioannou K, Athanasiou I, Panagidou A, Demetriou K, Zavros M. J Med Case Rep; 2014 Sep 14; 8():307. PubMed ID: 25219386 [Abstract] [Full Text] [Related]
4. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches]. Kistler AD. Praxis (Bern 1994); 2016 Mar 30; 105(7):389-96. PubMed ID: 27005733 [Abstract] [Full Text] [Related]
5. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report. Sengul Samanci N, Ayer M, Ergen A, Ozturk S. Transfus Apher Sci; 2015 Jun 30; 52(3):314-6. PubMed ID: 25634788 [Abstract] [Full Text] [Related]
8. Atypical Hemolytic Uremic Syndrome Associated with Complement Factor H Mutation and IgA Nephropathy: A Case Report Successfully Treated with Eculizumab. Nakamura H, Anayama M, Makino M, Makino Y, Tamura K, Nagasawa M. Nephron; 2018 Jun 30; 138(4):324-327. PubMed ID: 29241200 [Abstract] [Full Text] [Related]
9. Complement Activation and Thrombotic Microangiopathies. Palomo M, Blasco M, Molina P, Lozano M, Praga M, Torramade-Moix S, Martinez-Sanchez J, Cid J, Escolar G, Carreras E, Paules C, Crispi F, Quintana LF, Poch E, Rodas L, Goma E, Morelle J, Espinosa M, Morales E, Avila A, Cabello V, Ariceta G, Chocron S, Manrique J, Barros X, Martin N, Huerta A, Fraga-Rodriguez GM, Cao M, Martin M, Romera AM, Moreso F, Manonelles A, Gratacos E, Pereira A, Campistol JM, Diaz-Ricart M. Clin J Am Soc Nephrol; 2019 Dec 06; 14(12):1719-1732. PubMed ID: 31694864 [Abstract] [Full Text] [Related]
10. Autoimmune-type atypical hemolytic uremic syndrome treated with eculizumab as first-line therapy. Hisano M, Ashida A, Nakano E, Suehiro M, Yoshida Y, Matsumoto M, Miyata T, Fujimura Y, Hattori M. Pediatr Int; 2015 Apr 06; 57(2):313-7. PubMed ID: 25868950 [Abstract] [Full Text] [Related]
11. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report. Fontana F, Alfano G, Bardhushi E, Ligabue G, Giovanella S, Neri I, Cappelli G. Am J Case Rep; 2019 Oct 04; 20():1460-1465. PubMed ID: 31582717 [Abstract] [Full Text] [Related]
12. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series. Duineveld C, Verhave JC, Berger SP, van de Kar NCAJ, Wetzels JFM. Am J Kidney Dis; 2017 Dec 04; 70(6):770-777. PubMed ID: 28821363 [Abstract] [Full Text] [Related]
13. Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS. Cofiell R, Kukreja A, Bedard K, Yan Y, Mickle AP, Ogawa M, Bedrosian CL, Faas SJ. Blood; 2015 May 21; 125(21):3253-62. PubMed ID: 25833956 [Abstract] [Full Text] [Related]
14. [Human genetics in atypical hemolytic uremic syndrome-its role in diagnosis and treatment]. Knoop M, Haller H, Menne J. Internist (Berl); 2018 Aug 21; 59(8):799-804. PubMed ID: 29995248 [Abstract] [Full Text] [Related]
15. A life-threatening case of pregnancy-related atypical Haemolytic uremic syndrome and successful treatment with Eculizumab. Puri P, Hanxhiu A, O'Hara DV, Hsu D, Vucak-Dzumhur M. BMC Nephrol; 2020 Nov 17; 21(1):488. PubMed ID: 33203373 [Abstract] [Full Text] [Related]
16. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort. Nga HS, Palma LMP, Ernandes Neto M, Fernandes-Charpiot IMM, Garcia VD, Kist R, Miranda SMC, Macedo de Souza PA, Pereira GM, de Andrade LGM. PLoS One; 2021 Nov 17; 16(11):e0258319. PubMed ID: 34748552 [Abstract] [Full Text] [Related]
17. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report. Xie L, Nester CM, Reed AI, Zhang Y, Smith RJ, Thomas CP. Transplant Proc; 2012 Dec 17; 44(10):3037-40. PubMed ID: 23195022 [Abstract] [Full Text] [Related]
18. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome. Diamante Chiodini B, Davin JC, Corazza F, Khaldi K, Dahan K, Ismaili K, Adams B. Pediatrics; 2014 Jun 17; 133(6):e1764-8. PubMed ID: 24843055 [Abstract] [Full Text] [Related]
19. An extremely rare splice site mutation in the gene encoding complement factor I in a patient with atypical hemolytic uremic syndrome. Ipe TS, Lim J, Reyes MA, Ero M, Leveque C, Lewis B, Kain J. J Clin Apher; 2017 Dec 17; 32(6):584-588. PubMed ID: 28455885 [Abstract] [Full Text] [Related]
20. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea. Cheong HI, Jo SK, Yoon SS, Cho H, Kim JS, Kim YO, Koo JR, Park Y, Park YS, Shin JI, Yoo KH, Oh D. J Korean Med Sci; 2016 Oct 17; 31(10):1516-28. PubMed ID: 27550478 [Abstract] [Full Text] [Related] Page: [Next] [New Search]